IFP Advisors
AVIR icon

IFP Advisors’s Atea Pharmaceuticals AVIR Stock Holding History

IFP Advisors’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$380 Hold
73
– – ﹤0.01% 4745
2026
Q2 		$339 Buy
73
+69
+1,725% +$343 ﹤0.01% 4757
2026
Q1 		$22 Hold
4
– – ﹤0.01% 4910
2025
Q4 		$14 Buy
4
+1
+33% +$3 ﹤0.01% 4822
2025
Q3 		$9 Buy
+3
New +$10 ﹤0.01% 4786
2025
Q2 		– Hold
0
– – – 4381
2025
Q1 		– Hold
0
– – – 4014
2024
Q4 		– Hold
0
– – – 4217

Other funds holding AVIR

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Auour Investments
Auour Investments Woburn, Massachusetts $353M AUM 8.66% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Certified Advisory Corp
Certified Advisory Corp Altamonte Springs, Florida $1.2B AUM 14.78% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Sunpointe
Sunpointe St. Louis, Missouri $328M AUM 26.96% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

IFP Advisors's AVIR Position: Q3 2026 in Review

IFP Advisors held its Atea Pharmaceuticals (AVIR) position steady in Q3 2026 at 73 shares worth $380. The position accounts for ﹤0.01% of the portfolio, ranked #4745.

IFP Advisors first reported a position in AVIR in Q3 2025 and has held it in 5 quarters since. 28 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.

  • IFP Advisors held 73 shares of Atea Pharmaceuticals worth $380 as of Q3 2026.
  • IFP Advisors left its Atea Pharmaceuticals share count unchanged in Q3 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4745 holding.
  • IFP Advisors first reported a position in Atea Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 28 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.